http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5679663-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36e8050eec40967e1cbc39ff89f2607d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3241 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3211 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate | 1994-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1997-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cce6c83fbd85105e8183a3afdf1f74cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a4478f5c5bb03bc7dd43972fd10ada2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c643f36534b72cd18f699283e7b59aa3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88f4049fa3326630bd176780d7571d36 |
| publicationDate | 1997-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5679663-A |
| titleOfInvention | Pharmaceutical compounds |
| abstract | PCT No. PCT/IB94/00009 Sec. 371 Date Sep. 25, 1996 Sec. 102(e) Date Sep. 25, 1996 PCT Filed Jan. 10, 1994 PCT Pub. No. WO95/18810 PCT Pub. Date Jul. 13, 1995Compounds of formula (I) <IMAGE> (I) wherein each X separately is halogeno, hydroxy, C1-4 alkyl, C1-4 alkoxy, nitro or an unsubstituted or substituted amino group NRR' in which R and R' are each separately selected from hydrogen, C1-4 alkyl groups and C2-4 halogenated alkyl groups; wherein Y is halogeno, hydroxy, C1-4 alkoxy or an unsubstituted or substituted amino group NRR' in which R and R' are as defined above; wherein n represents 0, 1, 2 or 3 and n' represents 1, 2, 3 or 4; wherein R1 and R2 each separately represent hydrogen, halogeno, phenyl or a C1-4 alkyl group, or together represent a group =NOR'' in which R'' is hydrogen or is a group ZC(O)- or (ZO)2P(O)- where Z is a C1-4 alkyl group; and wherein R3 and R4 each separately represent hydrogen, acetyl, phenyl, 2,2,2-trichloro-1-hydroxyethyl or a C1-4 alkyl group, or together represent a group =CHR''' in which R''' is a C1-4 alkyl, C1-4 halogenated alkyl or phenyl group or represent a group =CH-CH=CHR''' in which R''' is as defined above; the compound or its physiologically acceptable salt, are of value in the treatment of depression and/or in memory enhancement. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2783121-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2799966-C1 |
| priorityDate | 1994-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 223.